Atea Pharmaceuticals to showcase positive hepatitis C treatment results at EASL 2025
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, announced that the full results from the… read more.